MorphoSys AG (MOR.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 11:30AM CEST. Market open.
| Previous close | 66.70 |
| Open | 66.75 |
| Bid | 66.90 x 27700 |
| Ask | 66.90 x 21000 |
| Day's range | 66.75 - 66.95 |
| 52-week range | 14.90 - 67.95 |
| Volume | |
| Avg. volume | 4,257 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 07 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
© 2024 Yahoo. All rights reserved.